{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:26:04Z","timestamp":1773393964324,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucagon has been shown to be beneficial as a treatment for bronchospasm in asthmatics. Here, we investigate if glucagon would prevent airway hyperreactivity (AHR), lung inflammation, and remodeling in a murine model of asthma. Glucagon (10 and 100\u2009\u00b5g\/Kg, i.n.) significantly prevented AHR and eosinophilia in BAL and peribronchiolar region induced by ovalbumin (OVA) challenge, while only the dose of 100\u2009\u00b5g\/Kg of glucagon inhibited subepithelial fibrosis and T lymphocytes accumulation in BAL and lung. The inhibitory action of glucagon occurred in parallel with reduction of OVA-induced generation of IL-4, IL-5, IL-13, TNF-\u03b1, eotaxin-1\/CCL11, and eotaxin-2\/CCL24 but not MDC\/CCL22 and TARC\/CCL17. The inhibitory effect of glucagon (100\u2009\u00b5g\/Kg, i.n.) on OVA-induced AHR and collagen deposition was reversed by pre-treatment with indomethacin (10\u2009mg\/Kg, i.p.). Glucagon increased intracellular cAMP levels and inhibits anti-CD3 plus anti-CD28-induced proliferation and production of IL-2, IL-4, IL-10, and TNF- \u03b1 from TCD4<jats:sup>+<\/jats:sup> cells <jats:italic>in vitro<\/jats:italic>. These findings suggest that glucagon reduces crucial features of asthma, including AHR, lung inflammation, and remodeling, in a mechanism probably associated with inhibition of eosinophils accumulation and TCD4<jats:sup>+<\/jats:sup> cell proliferation and function. Glucagon should be further investigated as an option for asthma therapy.<\/jats:p>","DOI":"10.1038\/s41598-019-42981-6","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T10:03:10Z","timestamp":1556100190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glucagon reduces airway hyperreactivity, inflammation, and remodeling induced by ovalbumin"],"prefix":"10.1038","volume":"9","author":[{"given":"Daniella B. R.","family":"Insuela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina T.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego S.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia S.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximiliano R.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Paula T.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Cascabulho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Henriques-Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla C.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno L.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M. R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato S. B.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2136-8958","authenticated-orcid":false,"given":"Vinicius F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"42981_CR1","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1172\/JCI43598","volume":"121","author":"M Yu","year":"2011","unstructured":"Yu, M. et al. Identification of an IFN-gamma\/mast cell axis in a mouse model of chronic asthma. The Journal of clinical investigation 121, 3133\u20133143, https:\/\/doi.org\/10.1172\/JCI43598 (2011).","journal-title":"The Journal of clinical investigation"},{"key":"42981_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pupt.2016.07.005","volume":"40","author":"I Sulaiman","year":"2016","unstructured":"Sulaiman, I., Lim, J. C., Soo, H. L. & Stanslas, J. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation. Pulmonary pharmacology & therapeutics 40, 52\u201368, https:\/\/doi.org\/10.1016\/j.pupt.2016.07.005 (2016).","journal-title":"Pulmonary pharmacology & therapeutics"},{"key":"42981_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nri2870","volume":"10","author":"CM Lloyd","year":"2010","unstructured":"Lloyd, C. M. & Hessel, E. M. Functions of T cells in asthma: more than just T(H)2 cells. Nature reviews. Immunology 10, 838\u2013848, https:\/\/doi.org\/10.1038\/nri2870 (2010).","journal-title":"Nature reviews. Immunology"},{"key":"42981_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy, J. V. Type 2 inflammation in asthma\u2013present in most, absent in many. Nature reviews. Immunology 15, 57\u201365, https:\/\/doi.org\/10.1038\/nri3786 (2015).","journal-title":"Nature reviews. Immunology"},{"key":"42981_CR5","doi-asserted-by":"publisher","first-page":"32899","DOI":"10.1074\/jbc.R110.206466","volume":"286","author":"PJ Barnes","year":"2011","unstructured":"Barnes, P. J. Biochemical basis of asthma therapy. The Journal of biological chemistry 286, 32899\u201332905, https:\/\/doi.org\/10.1074\/jbc.R110.206466 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"42981_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000288288","volume":"152","author":"K Futamura","year":"2010","unstructured":"Futamura, K. et al. beta2-Adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells. International archives of allergy and immunology 152, 353\u2013361, https:\/\/doi.org\/10.1159\/000288288 (2010).","journal-title":"International archives of allergy and immunology"},{"key":"42981_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2217\/bmm-2016-0090","volume":"10","author":"NJ Wewer Albrechtsen","year":"2016","unstructured":"Wewer Albrechtsen, N. J., Kuhre, R. E., Pedersen, J., Knop, F. K. & Holst, J. J. The biology of glucagon and the consequences of hyperglucagonemia. Biomarkers in medicine 10, 1141\u20131151, https:\/\/doi.org\/10.2217\/bmm-2016-0090 (2016).","journal-title":"Biomarkers in medicine"},{"key":"42981_CR8","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.90295.2008","volume":"295","author":"P Bansal","year":"2008","unstructured":"Bansal, P. & Wang, Q. Insulin as a physiological modulator of glucagon secretion. American journal of physiology. Endocrinology and metabolism 295, E751\u2013761, https:\/\/doi.org\/10.1152\/ajpendo.90295.2008 (2008).","journal-title":"American journal of physiology. Endocrinology and metabolism"},{"key":"42981_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.07.015","volume":"812","author":"DBR Insuela","year":"2017","unstructured":"Insuela, D. B. R. & Carvalho, V. F. Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds. European journal of pharmacology 812, 64\u201372, https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.015 (2017).","journal-title":"European journal of pharmacology"},{"key":"42981_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0735-6757(98)90100-0","volume":"16","author":"SW Melanson","year":"1998","unstructured":"Melanson, S. W., Bonfante, G. & Heller, M. B. Nebulized glucagon in the treatment of bronchospasm in asthmatic patients. The American journal of emergency medicine 16, 272\u2013275 (1998).","journal-title":"The American journal of emergency medicine"},{"key":"42981_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/0091-6749(88)90949-9","volume":"81","author":"MS Sherman","year":"1988","unstructured":"Sherman, M. S., Lazar, E. J. & Eichacker, P. A bronchodilator action of glucagon. The Journal of allergy and clinical immunology 81, 908\u2013911 (1988).","journal-title":"The Journal of allergy and clinical immunology"},{"key":"42981_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ajem.2016.09.063","volume":"35","author":"JM Cavallari","year":"2017","unstructured":"Cavallari, J. M., Jawaro, T. S., Awad, N. I. & Bridgeman, P. J. Glucagon for refractory asthma exacerbation. The American journal of emergency medicine 35, 144\u2013145, https:\/\/doi.org\/10.1016\/j.ajem.2016.09.063 (2017).","journal-title":"The American journal of emergency medicine"},{"key":"42981_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4172\/2155-6121.S11-001","volume":"S11","author":"DB Insuela","year":"2013","unstructured":"Insuela, D. B., Silva, P. M. R., Martins, M. A. & Carvalho, V. F. The Yin Yang of Hormones that Control Glucose Homeostasis in Asthma. Journal of Allergy & Therapy S11, 8, https:\/\/doi.org\/10.4172\/2155-6121.S11-001 (2013).","journal-title":"Journal of Allergy & Therapy"},{"key":"42981_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1530\/JOE-14-0648","volume":"225","author":"DB Insuela","year":"2015","unstructured":"Insuela, D. B. et al. Glucagon induces airway smooth muscle relaxation by nitric oxide and prostaglandin E(2). The Journal of endocrinology 225, 205\u2013217, https:\/\/doi.org\/10.1530\/JOE-14-0648 (2015).","journal-title":"The Journal of endocrinology"},{"key":"42981_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0021-8707(69)90001-X","volume":"44","author":"MN Blumenthal","year":"1969","unstructured":"Blumenthal, M. N. & Brody, T. M. Studies on the mechanism of drug-induced bronchiolar relaxation in the guinea pig. The Journal of allergy 44, 63\u201369 (1969).","journal-title":"The Journal of allergy"},{"key":"42981_CR16","first-page":"41","volume":"84","author":"AM Das","year":"1995","unstructured":"Das, A. M., Williams, T. J., Lobb, R. & Nourshargh, S. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology 84, 41\u201346 (1995).","journal-title":"Immunology"},{"key":"42981_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1084\/jem.186.4.601","volume":"186","author":"AA Humbles","year":"1997","unstructured":"Humbles, A. A. et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. The Journal of experimental medicine 186, 601\u2013612 (1997).","journal-title":"The Journal of experimental medicine"},{"key":"42981_CR18","first-page":"209","volume":"83","author":"M Strath","year":"1985","unstructured":"Strath, M., Warren, D. J. & Sanderson, C. J. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. Journal of immunological methods 83, 209\u2013215 (1985).","journal-title":"Its use as an assay for eosinophil differentiation factors. Journal of immunological methods"},{"key":"42981_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/ALN.0b013e31826687d5","volume":"117","author":"MF Serra","year":"2012","unstructured":"Serra, M. F. et al. Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. Anesthesiology 117, 580\u2013591, https:\/\/doi.org\/10.1097\/ALN.0b013e31826687d5 (2012).","journal-title":"Anesthesiology"},{"key":"42981_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fimmu.2017.00740","volume":"8","author":"DS Coutinho","year":"2017","unstructured":"Coutinho, D. S. et al. 15-Deoxy-Delta-12,14-Prostaglandin J2 Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma. Frontiers in immunology 8, 740, https:\/\/doi.org\/10.3389\/fimmu.2017.00740 (2017).","journal-title":"Frontiers in immunology"},{"key":"42981_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2222.2010.03580.x","volume":"41","author":"PC Olsen","year":"2011","unstructured":"Olsen, P. C. et al. Lidocaine-derivative JMF2-1 prevents ovalbumin-induced airway inflammation by regulating the function and survival of T cells. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 41, 250\u2013259, https:\/\/doi.org\/10.1111\/j.1365-2222.2010.03580.x (2011).","journal-title":"Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology"},{"key":"42981_CR22","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.4049\/jimmunol.0800891","volume":"182","author":"MT Bailey","year":"2009","unstructured":"Bailey, M. T. et al. Social stress enhances allergen-induced airway inflammation in mice and inhibits corticosteroid responsiveness of cytokine production. J Immunol 182, 7888\u20137896, https:\/\/doi.org\/10.4049\/jimmunol.0800891 (2009).","journal-title":"J Immunol"},{"key":"42981_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccm.2012.05.002","volume":"33","author":"JL Black","year":"2012","unstructured":"Black, J. L., Panettieri, R. A. Jr., Banerjee, A. & Berger, P. Airway smooth muscle in asthma: just a target for bronchodilation? Clinics in chest medicine 33, 543\u2013558, https:\/\/doi.org\/10.1016\/j.ccm.2012.05.002 (2012).","journal-title":"Clinics in chest medicine"},{"key":"42981_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphys.2012.00460","volume":"3","author":"JD Brannan","year":"2012","unstructured":"Brannan, J. D. & Lougheed, M. D. Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Frontiers in physiology 3, 460, https:\/\/doi.org\/10.3389\/fphys.2012.00460 (2012).","journal-title":"Frontiers in physiology"},{"key":"42981_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cea.12506","volume":"45","author":"DG Chapman","year":"2015","unstructured":"Chapman, D. G. & Irvin, C. G. Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 45, 706\u2013719, https:\/\/doi.org\/10.1111\/cea.12506 (2015).","journal-title":"Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology"},{"key":"42981_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fimmu.2017.00242","volume":"8","author":"G Varricchi","year":"2017","unstructured":"Varricchi, G. et al. Reslizumab and Eosinophilic Asthma: One Step Closer to Precision. Medicine? Frontiers in immunology 8, 242, https:\/\/doi.org\/10.3389\/fimmu.2017.00242 (2017).","journal-title":"Medicine? Frontiers in immunology"},{"key":"42981_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2011-0013TR","volume":"45","author":"M Wegmann","year":"2011","unstructured":"Wegmann, M. Targeting eosinophil biology in asthma therapy. American journal of respiratory cell and molecular biology 45, 667\u2013674, https:\/\/doi.org\/10.1165\/rcmb.2011-0013TR (2011).","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"42981_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1189\/jlb.0212074","volume":"94","author":"V Provost","year":"2013","unstructured":"Provost, V. et al. CCL26\/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11\/eotaxin-1 and CCL24\/eotaxin-2. Journal of leukocyte biology 94, 213\u2013222, https:\/\/doi.org\/10.1189\/jlb.0212074 (2013).","journal-title":"Journal of leukocyte biology"},{"key":"42981_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fmed.2017.00075","volume":"4","author":"MW Johansson","year":"2017","unstructured":"Johansson, M. W. Eosinophil Activation Status in Separate Compartments and Association with Asthma. Frontiers in medicine 4, 75, https:\/\/doi.org\/10.3389\/fmed.2017.00075 (2017).","journal-title":"Frontiers in medicine"},{"key":"42981_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00441-016-2566-8","volume":"367","author":"H Fehrenbach","year":"2017","unstructured":"Fehrenbach, H., Wagner, C. & Wegmann, M. Airway remodeling in asthma: what really matters. Cell and tissue research 367, 551\u2013569, https:\/\/doi.org\/10.1007\/s00441-016-2566-8 (2017).","journal-title":"Cell and tissue research"},{"key":"42981_CR31","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1155\/2010\/318029","volume":"17","author":"C Bergeron","year":"2010","unstructured":"Bergeron, C., Tulic, M. K. & Hamid, Q. Airway remodelling in asthma: from benchside to clinical practice. Canadian respiratory journal 17, e85\u201393 (2010).","journal-title":"Canadian respiratory journal"},{"key":"42981_CR32","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1096\/fj.11-203323","volume":"26","author":"SK Huang","year":"2012","unstructured":"Huang, S. K. et al. Prostaglandin E(2) increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26, 3703\u20133714, https:\/\/doi.org\/10.1096\/fj.11-203323 (2012).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"42981_CR33","doi-asserted-by":"publisher","first-page":"519298","DOI":"10.1155\/2010\/519298","volume":"2010","author":"C Vock","year":"2010","unstructured":"Vock, C., Hauber, H. P. & Wegmann, M. The other T helper cells in asthma pathogenesis. Journal of allergy 2010, 519298, https:\/\/doi.org\/10.1155\/2010\/519298 (2010).","journal-title":"Journal of allergy"},{"key":"42981_CR34","doi-asserted-by":"publisher","first-page":"11787","DOI":"10.1073\/pnas.90.24.11787","volume":"90","author":"EG Brooks","year":"1993","unstructured":"Brooks, E. G. et al. Human T-cell receptor (TCR) alpha\/beta\u2009+\u2009CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. Proceedings of the National Academy of Sciences of the United States of America 90, 11787\u201311791 (1993).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"42981_CR35","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.yexcr.2011.10.001","volume":"317","author":"L Krilov","year":"2011","unstructured":"Krilov, L. et al. Dual mode of glucagon receptor internalization: role of PKCalpha, GRKs and beta-arrestins. Experimental cell research 317, 2981\u20132994, https:\/\/doi.org\/10.1016\/j.yexcr.2011.10.001 (2011).","journal-title":"Experimental cell research"},{"key":"42981_CR36","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jaci.2010.08.014","volume":"126","author":"SL Jin","year":"2010","unstructured":"Jin, S. L. et al. Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma. The Journal of allergy and clinical immunology 126, 1252\u20131259 e1212, https:\/\/doi.org\/10.1016\/j.jaci.2010.08.014 (2010).","journal-title":"The Journal of allergy and clinical immunology"},{"key":"42981_CR37","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1530\/JOE-14-0614","volume":"224","author":"MJ Charron","year":"2015","unstructured":"Charron, M. J. & Vuguin, P. M. Lack of glucagon receptor signaling and its implications beyond glucose homeostasis. The Journal of endocrinology 224, R123\u2013130, https:\/\/doi.org\/10.1530\/JOE-14-0614 (2015).","journal-title":"The Journal of endocrinology"},{"key":"42981_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrendo.2015.51","volume":"11","author":"JE Campbell","year":"2015","unstructured":"Campbell, J. E. & Drucker, D. J. Islet alpha cells and glucagon\u2013critical regulators of energy homeostasis. Nature reviews. Endocrinology 11, 329\u2013338, https:\/\/doi.org\/10.1038\/nrendo.2015.51 (2015).","journal-title":"Nature reviews. Endocrinology"},{"key":"42981_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.peptides.2015.03.011","volume":"67","author":"B Ahren","year":"2015","unstructured":"Ahren, B. Glucagon\u2013Early breakthroughs and recent discoveries. Peptides 67, 74\u201381, https:\/\/doi.org\/10.1016\/j.peptides.2015.03.011 (2015).","journal-title":"Peptides"},{"key":"42981_CR40","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1007\/s00018-008-7479-6","volume":"65","author":"F Authier","year":"2008","unstructured":"Authier, F. & Desbuquois, B. Glucagon receptors. Cellular and molecular life sciences: CMLS 65, 1880\u20131899, https:\/\/doi.org\/10.1007\/s00018-008-7479-6 (2008).","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"42981_CR41","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00125-016-3965-9","volume":"59","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H., Wang, M. Y., Yu, X. X. & Unger, R. H. Glucagon is the key factor in the development of diabetes. Diabetologia 59, 1372\u20131375, https:\/\/doi.org\/10.1007\/s00125-016-3965-9 (2016).","journal-title":"Diabetologia"},{"key":"42981_CR42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1210\/endo-111-2-684","volume":"111","author":"SJ Bhathena","year":"1982","unstructured":"Bhathena, S. J. et al. Expression of glucagon receptors on T- and B- lymphoblasts: comparison with insulin receptors. Endocrinology 111, 684\u2013692, https:\/\/doi.org\/10.1210\/endo-111-2-684 (1982).","journal-title":"Endocrinology"},{"key":"42981_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0024-3205(95)02352-6","volume":"58","author":"WS Koh","year":"1996","unstructured":"Koh, W. S., Lee, M., Yang, K. H. & Kaminski, N. E. Expression of functional glucagon receptors on lymphoid cells. Life sciences 58, 741\u2013751 (1996).","journal-title":"Life sciences"},{"key":"42981_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0736-4679(93)90519-D","volume":"11","author":"CV Pollack Jr.","year":"1993","unstructured":"Pollack, C. V. Jr. Utility of glucagon in the emergency department. The Journal of emergency medicine 11, 195\u2013205 (1993).","journal-title":"The Journal of emergency medicine"},{"key":"42981_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0736-4679(90)90220-P","volume":"8","author":"JE Wilson","year":"1990","unstructured":"Wilson, J. E. & Nelson, R. N. Glucagon as a therapeutic agent in the treatment of asthma. The Journal of emergency medicine 8, 127\u2013130 (1990).","journal-title":"The Journal of emergency medicine"},{"key":"42981_CR46","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/j.1552-4604.1975.tb05920.x","volume":"15","author":"R Imbruce","year":"1975","unstructured":"Imbruce, R., Goldfedder, A., Maguire, W., Briscoe, W. & Nair, S. The effect of glucagon on airway resistance. Journal of clinical pharmacology 15, 680\u2013684 (1975).","journal-title":"Journal of clinical pharmacology"},{"key":"42981_CR47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1067\/mem.2000.110823","volume":"36","author":"ST Wilber","year":"2000","unstructured":"Wilber, S. T. et al. The bronchodilator effect of intravenous glucagon in asthma exacerbation: a randomized, controlled trial. Annals of emergency medicine 36, 427\u2013431, https:\/\/doi.org\/10.1067\/mem.2000.110823 (2000).","journal-title":"Annals of emergency medicine"},{"key":"42981_CR48","first-page":"390","volume":"27","author":"SD Lockey","year":"1969","unstructured":"Lockey, S. D. Sterile filtration of small volume allergenic preparations. Annals of allergy 27, 390\u2013392 (1969).","journal-title":"Annals of allergy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42981-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:04:10Z","timestamp":1671267850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42981-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42981-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6478"}}